Trial Profile
A Phase 1, Non-randomized, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Enzalutamide in Male Subjects With Severe Hepatic Impairment and Normal Hepatic Function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 19 May 2014 New trial record